Plants infected with cucumber mosaic virus (CMV) (KIN strain) produce a mild mosaic disease on tobacco whereas infections of CMV with satellite RNA (strain Y) cause a severe yellow mosaic. Analysis of recombinant and mutant forms of satellite RNA identified a site (nucleotides 185/186) in the Y satellite RNA that affects the ability to induce the yellow mosaic in combination with CMV but not with tomato aspermy virus. The location of this site with respect to other mutations in the satellite RNA indicated that polypeptides, which may be encoded by the satellite RNA, have no role in induction of yellow mosaic symptoms. The symptom induction is therefore an effect of the satellite RNA on the host plant with the intervention of the helper virus. In the course of the mutation analysis of satellite RNA we detected several secondary mutations which arose in planta. Two of these were deletions of more than 80 nucleotides. Other forms of mutant satellite RNA were non-functional even though the modifications involved nucleotides completely within the large secondary deletions. These data imply complex intramolecular interactions in the satellite RNA.
Introduction
Disease symptoms produced on plants infected with cucumber mosaic virus (CMV) may be modified by the presence of satellite RNA in the inoculum (Francki, 1985) . Some species of satellite RNA suppress CMV-induced symptoms, while others trigger new symptoms that are quite distinct from those of viral disease Waterworth et al., 1979; Jacquemond & Lot, 1981; Takanami, 1981; Gonsalves et al., 1982) . This disease modulation is dependent also on the type of host plant Masuta et al., 1988; Waterworth et al., 1979) and helper virus (Palukaitis, 1988; Masuta et al., 1988) . There is, therefore, evidence for a three-way interaction between the plant, the satellite RNA and the helper virus.
We are investigating the molecular basis of disease modification by satellite RNA using the Y satellite RNA which, together with CMV, induces a yellow mosaic disease of tobacco and a systemic necrosis of tomato t Present address: Department of Cell Biology and Genetics, Erasmus University, Rotterdam, P.O. Box 1738, 3000 DR Rotterdam, The Netherlands. (Takanami, 1981) . It has been shown previously (Devic et at., 1989 (Devic et at., , 1990 Masuta & Takanami, 1989 ) that these symptoms are affected by sequences in the 5' (yellow mosaic) and 3' (necrosis) parts of the molecule. In this report we describe an analysis of sequences affecting the yellow mosaic symptom. As before, the experimental approach involved analysis of recombinant and mutant forms of satellite RNA (Devic et al., 1989 (Devic et al., , 1990 . In our earlier work, the Y satellite hybrids were constructed using the Ra satellite RNA which induces neither yellow mosaic of tobacco nor tomato necrosis (Devic et al., 1989) . For analysis of the ability to induce yellow mosaic disease we chose the I17N' instead of the Ra satellite RNA. The only difference in symptom modulation between Y and I17N' satellite RNAs is the ability to induce the yellow mosaic on tobacco (Jacquemond & Lot, 1981; M. Jaegle, unpublished data) .
The interaction of Y satellite RNA with the helper virus was investigated by infection of recombinant satellite RNAs and either CMV or tomato aspermy cucumovirus (TAV) (Hollings & Stone, 1971) . TAV has only partial sequence homology (Habili & Francki, 1974b; Harrison et al., 1987) and no serological relationship with CMV (Habili & Francki, 1974a) but can replicate some isolates of CMV satellite RNA Harrison et al., 1987) .
Methods
Viral strains, satellite RNA and cDNA CMV-KIN and TAV (British strain) were obtained from Professor B. D. Harrison (Scottish Crop Research Institute, Invergowrie, U.K.) as a sample of total nucleic acids from infected tobacco leaves. Y satellite RNA was provided by Dr Y. Takanami (Japanese Salt & Tobacco Company) (Devic et al., 1989) . I17N satellite RNA was provided by Dr M. Jacquemond (INRA, Montfavet, France) in a dried leaf sample and was propagated in tobacco. The accession received was designated I 17N' satellite RNA in order to distinguish it from the I17N satellite RNA described by Jacquemond & Lauquin (1988) (see Results section). Satellite eDNA clones were described previously in Devic et al. (1989) (Y satellite RNA) and Baulcombe et al. (1986) (I17N" satellite RNA) . The inocula of CMV-KIN and TAV used as helper viruses were extracts of total nucleic acids from infected plants that were prepared as described by Devic et al. (1989) .
Virus purification. CMV-KIN was purified by the method of Lot et al. (1972) . RNA was extracted by the phenol-SDS method (Devic et al., 1989) .
Oligonucleotide-directed mutagenesis. Specific mutagenesis was carried out in a two-step procedure by polymerase chain reaction (PCR) as described by Higuchi et aL (1988) but with some modifications. In the first stage two separate reactions were carried out using a mutagenic primer and a second primer that was from either the 5' or 3' end of the satellite cDNA. The mutagenic primers were partially complementary so that the products of the first stage reactions could be annealed in the second stage PCR reaction together with the 5' and 3' primers to produce a full-length cDNA that incorporated the mutated sequence. The first stage reactions contained the following components: 1 ng of plasmid DNA, 200 ~tM each of dATP, dGTP, dCTP and TTP, 10 pmol of each primer, 2-5 units (U) ofTaq DNA polymerase, 50 mM-KCI, 10 mM-Tris-HC1 pH 8.3, 2.5 mM-MgCI2 and 0-01% gelatin (w/v). The reactions were carried out for 25 cycles of 94 °C for 1 rain, annealing for 2 min and extension at 72 °C for 2 rain. The annealing temperature was at T,~ -5 °C for the least stable primer. T~ was calculated according to the formula Tm= (4A) + (2B) where A and B are the number of G + C and A + T residues respectively (Sambrook et al., 1989) . The PCR product was purified from excess primer by electrophoresis in agarose. In the second stage reaction the conditions were as in the first stage except that the template was 1 to 5 ng DNA product from each of the first reactions, rather than plasmid DNA.
In vitro transcription, infectivity assay and Northern blot analysis. The details of these procedures were given by Devic et al. (1989) . For transcription the satellite cDNA was made linear by digestion with Sinai and transcribed in vitro with E. coli RNA polymerase. The transcripts of 1.25 lxg of plasmid DNA were inoculated into tobacco (Nicotiana tabacum cv. Samsun NN) seedlings with 20 ~tg of total nucleic acid from plants infected with the appropriate helper virus. Each construction was analysed in at least two experiments. The numbers of plants tested are indicated in the text.
RNA was isolated from systemically infected leaves 14 days after infection, using a buffer containing SDS and proteinase K and several extractions with phenol/chloroform. For Northern blot analysis the RNA was fractionated by electrophoresis on formaldehyde/agarose gels. The Northern blots were probed with cloned cDNA of I17N' satellite RNA.
PCR and sequencing of the progeny satellite RNA molecules. The total nucleic acid extract of infected plants was annealed with a primer complementary to the 3' end of I17N' satellite RNA (18-mer) and the progeny satellite RNA was reverse-transcribed. The cDNA was amplified by PCR as described above using primers from the 3' and 5' ends of satellite cDNA. The PCR product was sequenced either directly or after cloning in a plasmid vector. Duplicate clones were sequenced to confirm that the sequence was representative of abundant species in the population of satellite RNA. Details of these procedures were given by Devic et al. (1989) . The cDNA of A109/191 (see Results section) was amplified by PCR using a 3' primer as described above and a 5' primer from the region including a BamHI site of Y satellite cDNA.
Sequence alignment. Sequences were aligned using the computer program GAP (Devereux et al., 1984) . The coordinates of nucleotide positions in the I17N' and mutant forms of satellite RNA refer to homologous positions in the Y satellite RNA (Fig. 1) .
Nomenclature of plasmids and recombinant RNA molecules. The nomenclature of recombinant molecules describes the source of the 5' and 3' regions in the cDNA, the source of the middle region and the sites of recombination. Plasmid molecules including the Pr promoter are given the prefix pPr. Thus, pPrlI7N'Y81/219 is a plasmid containing the Pr promoter of the plasmid pPM1 (Ahlquist & Janda, 1984) with a recombinant satellite cDNA in which the 5' and 3' regions from the I 17N' satellite RNA are linked at nucleotides 81 and 219 to the middle region from the Y satellite RNA. Transcripts from the various cDNAs are named without the prefix.
Results

Identification of the domain affecting yellow mosaic symptoms (i) Construction of chimeric satellite RNAs
The sequence of I17N' satellite RNA (derived from cDNA) is shown aligned to the Y satellite RNA sequence (Fig. 1) . Two cDNA clones of I17N' were analysed by sequencing (D. Baulcombe, unpublished data) . Both differ at position 359 ( Fig. 1) sequence of I17N (Jacquemond & Lauquin, 1988) . The differences between the I17N' and Y satellite RNA sequences are mainly in the central region where there is a potential 35 nucleotide stem/loop structure (Hidaka et al., 1988) , which is absent from I17N', flanked by regions of partial similarity between the two sequences. Devic et al. (1989) showed that there are separate regions in the Y satellite RNA that affect symptoms: a 5" region affecting yellow mosaic on tobacco and a 3' region inducing systemic necrosis on tomato. In order to delineate the region affecting the yellow mosaic, six chimeric satellite RNAs were constructed based on the Y and I17N' satellite RNA sequences (Fig. 2) . In each construction the 3' side of the chimeric zone was an NheI site known to be outside the yellow mosaic domain (Devic et al., 1989) . The 5' limits of the hybrid zone corresponded to restriction enzyme sites that occurred naturally or could be engineered into the cDNAs (Fig. 2) . The DdeI site was outside the region of heterogeneity between Y and I17N' RNAs, the XhoI site was at its boundary and the 5' BssHII site was at the base of the putative 35 nucleotide stem/loop structure ( Fig. 1) . In order to construct these hybrids, XhoI and BssHII restriction sites were created by in vitro mutagenesis. To create an XhoI restriction site we altered nucleotides 107 and 108 changing the sequence from CTCGGA to CTCGAG in both satellite RNAs. To create the 5' BssHII ( Fig. 1 ) restriction site we changed position 129 (G to C) and position 131 (T to C) in Y satellite cDNA and position 129 (A to C) in I17N' satellite cDNA. These small changes to the Y and I17N' sequences had no effect on symptoms when transcripts of the cDNA were inoculated on tobacco plants along with CMV helper virus (M. Jaegle, unpublished data). The final structure of each hybrid cDNA is presented in Fig. 2 .
Analysis of results obtained with these constructions was complicated by rearrangements that arose during accumulation in planta of two of the chimeric satellite RNAs. These rearrangements were detected in the systemic leaves of plants inoculated with the in vitro transcripts. The progeny that arose from the I 17N'Y 103/ 219 construct was mutated at six positions between nucleotides 94 and 103 and was thus identical to the chimeric satellite RNA I17N'Y81/219. It is unlikely that this result was a consequence of contamination in the glasshouse as a similar set of mutations was observed in three independent experiments when I17N'Y103/219 was inoculated with CMV. The progeny of II7N'Y126/ 219 had undergone a more radical rearrangement and was obviously smaller than the inoculated RNA species when examined by Northern blot analysis (data not shown). The analysis of this deleted form of satellite RNA is described in more detail below. Other constructions described in Fig. 2 gave rise to progeny RNA that had the same nucleotide sequence as the inoculum.
The induction of yellow mosaic symptoms implies that in the chimeric satellite RNA, of the sequence differences between the Y and I17N" RNAs, those which are within the Y component of the chimera include those which are necessary for the symptom induction; absence of yellow mosaic symptoms implies that at least one of the differences within the I17N' part of the chimera is required for the induction of symptoms although other differences outside the I 17'N part may also be important. Thus, as the I17N'Y81/219 RNA induced yellow mosaic, the necessary differences are all between nucleotides 81 and 219 at sites which differ in Y and I17N' satellite RNAs. However, within that region, these RNAs are identical on the 5' side of position 95 and on the 3' side of position 194. Thus, the sequence differences which are necessary for yellow mosaic symptoms are between nucleotides 95 and 194. The series of chimeras with the YI17N' format all failed to induce yellow mosaic, implying that at least one nucleotide of a yellow mosaic determinant is between nucleotides 126 and 194 (YI17N'126/219). As is discussed later, these experiments do not detect parts of symptom-inducing domains which are identical in both types of satellite RNA. .. ******************************* ******************************************************************************************* ******************************************************************************************* ******************************************************************************************* ************************* ................................... ******************************* ******************************************************************************************* ******************************************************************************************* ******************************************************************************************* ******************************************************************************************* ******************************************************************************************* mosaic determinant more precisely (Fig. 3) . Mutant pY-35, a deletion of the putative stem/loop structure in Y satellite RNA (Hidaka et al., 1988) , was constructed in two stages. The first stage was the introduction of BssHII sites at positions 126 and 161 (Fig. 1 ) by site-directed mutagenesis. In the second stage the region between the BssHII sites was deleted. However, when transcripts of pY-35 were tested for biological activity in the presence of CMV helper virus, satellite RNA was not recovered from any of the seven plants inoculated. Other mutations were introduced in the regions flanking the stem/loop structure where there is partial similarity between the Y and I17N' satellite RNAs. These mutations were designed to modify local regions of Y satellite RNA to resemble exactly the I17N' satellite RNA (Fig. 3) . Transcripts of the mutant cDNA were coinoculated with CMV and total RNA was extracted from systemically infected leaves after 2 weeks for analysis of the progeny RNA. All mutants, except Y2 and Y4, accumulated in infected leaves (Table 1) but the mutant satellite RNA accumulated without the induction of yellow mosaic only with Y6 (Table 1 ). The sequences of progeny of mutant satellite RNAs described in Fig. 3 were identical to those of the inoculum except in the instance of Y6. The progeny RNA of Y6 included some molecules that were identical to the inoculum and others which had reverted at nucleotide 185 (U to C). We did not determine the ratio of these two types of molecule in planta. However, this result suggests that the change of positions 185 and/or 186 is sufficient to alter the potential of Y satellite RNA to induce yellow mosaic symptoms.
In an attempt to introduce the yellow mosaic function to the I17N' satellite RNA, we replaced 18 bases of I17N' satellite RNA with 19 bases of Y satellite RNA over a region that includes the nucleotides at positions 185 and 186 shown to affect symptom expression (CUACUCUCAGUACUACAC to ACUUUUU-CAGCUCUGCAUU; I17N'Y175/193). Two weeks post-inoculation to tobacco with CMV helper virus, none of 10 plants were yellow, one showed attenuation of viral symptoms and the other nine showed CMV symptoms. The plant showing attenuation of viral symptoms was the only one with satellite RNA. A Northern blot showed that this RNA molecule migrated at a rate similar to that of the deleted progeny RNA obtained from the recombinant transcripts of I17N'YI26/219 described above (data not shown). Sequence analysis showed that 82 nucleotides had been deleted between nucleotides 105 and 188 (Fig. 4a) . This deleted molecule (A105/188) was not analysed further.
In the second attempt at mutagenesis of I17N' to a form that would induce yellow mosaic, we modified only two bases (nucleotides 185 to C and 186 to U) in the I17N' satellite cDNA (I17N'Y185/186). When transcripts of the cDNA were inoculated with CMV to 12 tobacco plants, at 2 weeks post-inoculation all plants showed attenuation of viral symptoms. The sequence of the accumulated satellite RNAs revealed that in each plant nucleotide 185 had reverted from C to U. This result indicates that a U at nucleotide 186 is not sufficient to characterize a satellite RNA capable of inducing a yellow mosaic on tobacco. YI 17N'81/219) (Fig. 2) . Total R N A was extracted from infected leaves and the presence of satellite R N A progeny was analysed by Northern blotting (Fig. 5) and sequence determination. With T A V as helper virus, satellite R N A was recovered only from plants inoculated with I17N'Y81/219. When CMV was helper, both hybrids replicated faithfully. There was variation between samples in the amount of satellite RNA (Fig. 5 ) but this variation does not reflect consistent differences in the accumulation of the natural and modified forms of satellite RNA.
From these results we conclude that the induction of yellow mosaic symptoms was a specifc effect of Y satellite RNA with CMV rather than TAV as helper virus. In addition it is clear from the results with YI17N'81/219 that the termini of the Y satellite RNA (nucleotides 1 to 81 and 219 to 369) are incompatible with the TAV helper virus. This incompatibility may be influenced by subtle changes in the nucleotide sequence as there are only four positions in the terminal regions (nucleotides 1 to 81 and 219 to 369) where the Y satellite RNA differs from the I17N' (Fig. 1) , Ra (Devic et al., 1989) or Q (Gordon & Symons, 1983) satellite RNAs that are helped by TAV ; M. Jaegle, unpublished data and Fig. 4 ). These differences are positions 51 (C in Y satellite RNA, U in the others), 252 (U for C), 257 (A deleted in Y) and 291 (G for U; Fig. 1 ).
Satellite RNA-encoded polypeptides play no role in yellow mosaic symptom expression
Y satellite RNA contains three potential open reading frames (ORFs I, IIA' and liB) (Devic etal., 1989;  Fig. 1 ). ORFIIA' and ORFIIB both overlap the yellow mosaic domain and may therefore be implicated in the mechanism of symptom expression. Two frameshift mutants were created to test this hypothesis; mutant Y3 has three base changes, one base inserted at position 122 that shifts the frame of ORFIIA' (Fig. 3) . Mutant Y8 has the G at position 153 deleted which shifts the frame of ORFIIB (Fig. 3) . In the presence of CMV helper virus on tobacco both of these mutants induced a yellow mosaic indistinguishable from that induced by Y satellite RNA. The sequence of the progeny RNA corresponded exactly to the inoculum. These results therefore rule out the possibility that polypeptides from ORFIIA' or ORFIIB are involved in induction of yellow mosaic symptoms.
Deleted forms of satellite RNA
The sequence of progeny RNA from I17N'Y126/219 was deleted between nucleotides 109 and 191 (Fig. 4b) , a region which encompasses the nucleotides affecting yellow mosaic symptoms on tobacco (Fig. 2) . The deletion is similar in size and location to the sequence of A105/188 (Fig. 4a) 
Discussion
We have shown in this paper that one or both of the nucleotides 185 and 186 of the Y satellite RNA affects the production of yellow mosaic symptoms in tobacco with CMV helper virus. This extends our earlier work (Devic et al., 1989) and the work of Masuta & Takanami (1989) that located sequences affecting yellow mosaic between positions 15t and 223. Also in agreement with Masuta & Takanami (1989) we have ruled out the involvement of polypeptides, which may be encoded by the Y satellite RNA (Hidaka et al., 1988; Devic et al., 1989) , in the induction of yellow mosaic symptoms. This result implies the involvement of a symptom-inducing structure in the satellite RNA. However, the precise nature of this structure cannot be determined from the present data for several reasons. We have not carried out an exhaustive mutagenesis so that the involvement of some positions either individually, or in certain combinations, has not been tested. Some mutations apparently affect the ability of the satellite RNA to accumulate in tobacco (e.g. Y2 and Y4, Fig. 3 ) so that not all possible sites can be tested. Our experimental approach would not detect the involvement of sequences that are conserved as the mutations were at sites of difference between symptom-inducing and benign forms of satellite RNA. Despite these uncertainties, it is clear that the active RNA structure is not simply a short stretch of contiguous nucleotides. For example, the natural $19 satellite RNA (Masuta & Takanami, 1989 ) is identical to the Y satellite RNA in the vicinity of nucleotide 185/186, but did not induce yellow mosaic symptoms on CMV-infected tobacco. Presumably the S19 RNA differs from the yellow mosaic-inducing form at other sites in the active RNA structure. It has been suggested that the putative stem-loop between nucleotides 128 and 166 may be involved in symptom induction (Masuta & Takanami, 1989) . Although there are no experimental data to rule this out, the existing experimental evidence implicates structures outside the stem-loop; nucleotide 185/186 is on the 3' side of the stem-loop. In addition, the B2 satellite RNA induces a yellow mosaic symptom but lacks a stem-loop similar to that in the central part of the Y satellite RNA (Palukaitis, 1988) . Our results also suggest that the yellow mosaic disease is not a simple consequence of the accumulation of the satellite RNA. The hybrid satellite RNA I17N'Y81/219 was replicated to similar levels by both CMV and TAV (Fig. 5 ), but induced yellow mosaic only in the presence of CMV. The yellow mosaic disease in therefore similar to the systemic necrosis and white leaf diseases induced in tomato by other satellite RNAs in that the effect is produced by the satellite RNA and helper virus acting together (Masuta et al., 1988; Palukaitis, 1988) . This finding raises a question concerning the action of satellite RNA; does satellite RNA act by exacerbation of one or more components of the viral disease syndrome, or does it act through a completely new route of symptom formation? CMV can induce yellowing in the absence of satellite RNA, as shown by the effects of M CMV (Francki et al., 1982) . However, yellowing induced by M CMV is associated with severe effects on chloroplast morphology whereas the satellite RNA-induced symptoms are associated with only a slight effect on thylakoid stacking (K. Plaskitt & D. C. Baulcombe, unpublished data). Thus the satellite RNA does not modify CMV strains to act in the same way as M CMV.
Although many of the mutated forms of satellite RNA were stable in infected plants, it is clear from data presented here and elsewhere (Devic et al., 1990; Collmer & Kaper, 1988 ) that satellite RNA accumulation is sensitive to small changes in the sequence of particular regions of the molecule. Some mutations completely abolish the ability of the satellite RNA to accumulate on helper virus-infected plants (Table 1) . Other mutations did not prevent satellite accumulation, but secondary mutations arose in planta which presumably neutralized the adverse effect of the primary mutation (e.g. II7N'Y103/219, Y6, I17N'185/186 and Devic et al., 1990) . With this sensitivity to small sequence alterations it was therefore surprising to discover that some forms of satellite RNA (A109/191 or A105/188; Fig. 4 ) with large internal deletions could accumulate in plants. It is suggested, as both deletions have similar boundaries, that the regions 105 to 109 and 199 to 191 delineate a structural domain in the satellite RNA which may be deleted without perturbing essential structures or molecular interactions involving the rest of the satellite RNA. In order to explain why smaller deletions do not accumulate in tobacco with CMV helper virus we propose that the residual parts of the 105 to 191 domain can interfere with these essential structures or molecular interactions. Unfortunately the model for the structure of Y satellite RNA (Hidaka et al., 1988) neither corroborates nor contradicts the existence of a discrete domain between nucleotides 105 and 191 : the boundaries of A109/191 and A105/188 do not coincide with obvious structures in the model whereas the mutant Y-35 (Fig. 3) , which does not function in plants with CMV helper, has a deletion at the base of a putative stem-loop structure (Hidaka et al., 1988) .
Expression of the I17N' satellite RNA from a transgene in tobacco plants is a method for genetically engineering virus resistance (Harrison et al., 1987) . However, this approach may involve environmental hazards (Nelson et al., 1988) which could be eliminated through the expression of disabled forms of satellite RNA that cannot be acquired and transmitted by CMV (Baulcombe et al., 1986) and in which sequences affecting symptom production have been deleted or modified. It is not yet known to what extent At05/188 or A109/191 fit those requirements.
